Academic challenges on ATMPs’ development: a regulatory perspective
Eulalia Olesti1,2,3*, Yoana Nuevo4, Elena Guillen1,2, Juan Bascuas1,2, Sara Varea1,2, Joaquín Saez-Peñataro1,2;3, Gonzalo Calvo1,2*
1 Department of Clinical Pharmacology, Area Medicament, Hospital Clinic of Barcelona, Spain.
2 Clinical Pharmacology, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
3 Department of Pharmacology, University of Barcelona, Spain.
4 Innovation Office and National Scientific Advice Unit, Spanish Agency of Medicines and Medical Devices (AEMPS).
*Corresponding authors: olesti@clinic.cat ;